Business Wire

MINISTRY-FOREIGN-JAPAN

29.2.2024 14:19:31 CET | Business Wire | Press release

Share
Japan Hosted a Conference to Boost Ukraine’s Economic Growth and Recovery

On February 19th, representatives of the governments of Japan and Ukraine, as well as business organizations, gathered in Tokyo for the Japan-Ukraine Conference for Promotion of Economic Growth and Reconstruction.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240229458562/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Prime Minister Kishida Fumio emphasized how Japan can contribute to Ukraine’s post-war reconstruction. (Photo by: Cabinet Public Affairs Office)

The Japanese government delegation, led by Prime Minister of Japan Kishida Fumio, pledged long-term support for Ukraine's recovery through public-private partnership. The Ukrainian delegation, led by Prime Minister of Ukraine Denys Shmyhal, thanked Japan for its assistance and invited Japanese businesses to invest in Ukraine's reconstruction. Each delegation consisted of more than 100 government and corporate officials. In total, around 300 people and 130 companies took part in the conference. The two governments agreed to cooperate on seven key areas: land mine action and debris clearance, humanitarian aid and livelihood reconstruction, agricultural development, biotechnology, digital and information technology, transportation and energy infrastructure, and anti-corruption and governance-strengthening measures.

In his keynote speech, Prime Minister Kishida described supporting Ukraine's recovery from the ongoing war as "investing in the future," and called on the international community to contribute. “Japan’s public and private sectors will all work together through an all-Japan approach, utilizing the knowledge derived from Japan’s postwar and disaster reconstruction efforts,” he said in his speech. “The promotion of economic reconstruction, however, is not only investment for the future of Ukraine but also investing in Japan and the whole globe.” He outlined new initiatives for Japan's public and private sectors to support Ukraine. Kishida also announced that Japan would ease entry visa requirements for Ukrainian citizens involving in Japan-Ukraine cooperation projects.

Prime Minister Shmyhal thanked Japan for its ongoing assistance and Prime Minister Kishida for his visit to Ukraine in 2023. He added “Today’s conference will be the next step towards continuing the development of both countries’ relationships.” Shmyhal mentioned the financial success of Japanese companies in Ukraine so far and invited businesses to further invest in the coming “Ukrainian economic miracle.” He underlined key sectors such as energy, agriculture, and infrastructure as offering prime investment opportunities with robust growth potential.

Both leaders emphasized their commitment to cooperation, as well as the importance of the private sector in Ukraine's reconstruction.

The conference resulted in the announcement of 56 documents, including inter-governmental agreements. The two governments signed a convention eliminating double taxation, which will support Japanese companies to invest in Ukraine. They also signed an agreement on bilateral crediting, exchanged notes concerning a grant aid for emergency recovery, and pledged to collaborate in the fields of education and technology.

Other documents included deals between government agencies and individual businesses and business organizations. Japanese companies signed deals with Ukrainian companies and government agencies to develop energy facilities, rebuild infrastructure, remove land mines, and more.

Since the Russian invasion in February 2022, Japan has consistently provided humanitarian aid and other assistance to Ukraine. With the public-private partnership announced at this conference, Japan plans to use its technological expertise and experience in post-disaster recovery and reconstruction to strengthen its support for Ukraine.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240229458562/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Presents Phase 1/2 Multidose Data for VGA039 (Latarcibart) at ISTH 2026, Showing Substantial Bleed Reductions in Patients with all Von Willebrand Disease Types13.7.2026 10:00:00 CEST | Press release

- Treatment with latarcibart led to an 81% median reduction in annualized bleeding rate (ABR) across all bleeding categories and patient types with von Willebrand disease (VWD) - Latarcibart, administered via a once monthly subcutaneous dosing regimen, was shown to be safe and well tolerated over multiple doses in this study - Pivotal Phase 3 VIVID-6 trial evaluating latarcibart’s potential to be the first targeted therapy for VWD is currently enrolling Incyte (Nasdaq: INCY) today announced complete safety and efficacy data from all patients (n=16) enrolled in the Phase 1/2 multidose study of VGA039 (latarcibart), a novel, Protein S-targeting, investigational monoclonal antibody for patients with von Willebrand disease (VWD). The data are being shared in an oral presentation today at the 34th Congress of the International Society on Thrombosis and Haemostasis (ISTH 2026 Congress) in Paris. Latarcibart modulates Protein S to improve hemostasis, potentially enhancing the body’s ability t

Europe’s Demand for Tech Services Accelerates in Q2, As Spending on AI and Managed Services Rises: ISG Index™13.7.2026 10:00:00 CEST | Press release

Combined market up 46%, led by 64% growth in cloud servicesManaged services up 21%, as companies seek cost savings to fund AI Demand for technology services in Europe continued to accelerate in the second quarter, as the region increasingly turns to managed services to reduce costs and cloud services to meet AI objectives, according to the latest state-of-the-industry report from Information Services Group (ISG) (Nasdaq: III), a global AI-centered technology research and advisory firm. The EMEA ISG Index™, which measures commercial outsourcing contracts with annual contract value (ACV) of US $5 million or more, shows second-quarter ACV for the combined market (both managed services and cloud-based as-a-service) soared 46 percent—its largest growth in eight years—to US $13.0 billion. The latest quarter adds to a string of three straight quarters in which growth has averaged 33 percent. “Europe has become the fastest-growing region for technology services, fueled not only by an increasin

Maureen Mahr von Staszewski Joins Heitman European Leadership Team13.7.2026 09:30:00 CEST | Press release

Heitman expands European platform with addition of experienced leader Heitman LLC (“Heitman”), a global real estate investment management firm, today announced the appointment of Maureen Mahr von Staszewski as Managing Director in the firm’s European Real Estate Investment team. As part of Heitman’s European leadership team, Maureen will help drive continued expansion across Europe, supporting the firm’s strategic growth initiatives, capital raising efforts, and investment activity across the region. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260713202147/en/ Maureen Mahr von Staszewski Joins Heitman European Leadership Team “We are excited Maureen has joined the Heitman team,” said Caleb Mercer, Managing Director and Head of European Investment at Heitman. “Her breadth and depth of experience in European real estate investment management will help strengthen our innovative and differentiated investment capabilities acro

LTM Partners with Anthropic to Accelerate Claude Adoption and Expand Enterprise Delivery13.7.2026 08:16:00 CEST | Press release

Claude and Claude Code embedded into LTM BlueVerse™ AI Delivery Fabric to power AI-led transformations LTM, the Business Creativity partner to the world's largest enterprises, today announced a partnership with Anthropic, the frontier AI company behind Claude, to accelerate enterprise-scale adoption of Claude, Claude Code and Claude Cowork across engineering, modernization, and business workflows. LTM will combine Claude, Claude Code and Claude Cowork with its enterprise implementation expertise to help clients move from pilots to production with market-leading productivity, throughput, quality underscored by assurance and transparency. LTM will specifically bring this expertise and capability to BFSI, Hi-Tech, Consumer and Production Industry domains. The three strategic focus areas of partnership include:LTM BlueVerse™: AI Delivery Fabric LTM BlueVerse AI Delivery Fabric will serve as the enterprise implementation layer for Claude adoption, integrating Claude and Claude Code into del

Sofinnova Partners Appoints David Evans as Partner13.7.2026 08:00:00 CEST | Press release

Sofinnova strengthens its growth strategy with a high-caliber London-based Partner:Physician-scientist combining frontline clinical experience, health financing and policy expertise, and a proven track record in venture capitalOver 20 years in drug development at Bristol Myers Squibb, Eli Lilly, and the Roche Venture Fund as well as in healthcare policy and financing Sofinnova Partners ("Sofinnova"), a leading European venture capital firm in life sciences, based in Paris, London, and Milan, announced the appointment of David Evans as Partner. A physician-scientist with deep pharma and drug development expertise, Evans joins from the Roche Venture Fund, where he most recently served as Senior Investment Director. His career spans frontline patient care as a doctor in Australia and with Médecins Sans Frontières, health policy and financing at the World Bank, and roles across the pharmaceutical industry in health economics & outcomes research and drug development before moving into life-

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye